SGHT CFO receives ~$100,000 RSU grant; 16-quarter vesting
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Sight Sciences (SGHT) disclosed a Form 4 for its Chief Financial Officer, reporting an equity award tied to service. On November 11, 2025, the officer acquired 15,337 shares of common stock at $0, reflecting settlement of a new grant of restricted stock units (RSUs) under the company’s 2021 Incentive Award Plan. Following the transaction, the officer beneficially owns 161,363 shares, held directly.
The RSU grant equals approximately $100,000 of common stock based on the grant-date price and vests in 16 equal quarterly installments from December 31, 2025 through September 30, 2029. Each RSU represents the right to receive one share of common stock and has no expiration date.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Rodberg James
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 15,337 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 161,363 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did Sight Sciences (SGHT) report on the Form 4?
A grant of RSUs to the CFO that resulted in the acquisition of 15,337 shares at $0, with total beneficial ownership at 161,363 shares.
How do the RSUs for SGHT’s CFO vest?
They vest in 16 equal quarterly installments from December 31, 2025 through September 30, 2029.
What is the value basis of the RSU grant for SGHT?
The grant equals approximately $100,000 of common stock based on the November 11, 2025 grant-date price.
Under which plan were the RSUs granted at SGHT?
The RSUs were granted under the company’s 2021 Incentive Award Plan.
What does each RSU represent for SGHT?
Each RSU represents a contingent right to receive one share of SGHT common stock and has no expiration date.